Uterine stimulants and relaxants

Last updated: June 19, 2025

Uterine stimulants and relaxants

PGreen

PGreen

Cell-cell junctions
Marfan syndrome
Cellular structure and function
Development of the renal system
Mitosis and meiosis
Colorectal polyps and cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Angina pectoris
Aortic valve disease
Coarctation of the aorta
Heart failure
Pneumonia
Tetralogy of Fallot
Shock
Mitral valve disease
Pericarditis and pericardial effusion
Pleural effusion
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Pelvic inflammatory disease
Testosterone
Polycystic ovary syndrome
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Thyroid hormones
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Selective permeability of the cell membrane
Cell cycle
Free radicals and cellular injury
Autosomal trisomies: Pathology review
Breast cancer: Pathology review
Hypertension: Pathology review
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Peripheral artery disease
Pulmonary edema
Restrictive lung diseases
Stroke volume, ejection fraction, and cardiac output
Ventilation-perfusion ratios and V/Q mismatch
Cranial nerves
Migraine
Myasthenia gravis
Abnormal uterine bleeding: Clinical
Neisseria gonorrhoeae
Primary adrenal insufficiency
Benign prostatic hyperplasia
Hodgkin lymphoma
Introduction to the immune system
Celiac disease
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Vitamin B12 deficiency
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Adrenergic antagonists: Beta blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Vaccinations
Anthelmintic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Anti-parkinson medications
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Headaches: Clinical
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus
Pediatric infectious rashes: Clinical

Transcript

Watch video only

Uterine stimulants and relaxants, as their names suggest, are medications used to induce or inhibit contractions of the uterus.

Uterine stimulants are also called uterotonics, because they increase the tone of the muscles of the uterus.

They’re mainly used to induce or facilitate labor, to reduce postpartum hemorrhage, and to induce abortion.

Uterine relaxants are also called tocolytics, where ‘toco-’ refers to childbirth, and ‘-lytic’ means to terminate.

They’re used to stop premature labor inorder to give time for the fetal lungs to mature.

So, the uterus is a super important organ in the female body, because not only does it allow the development of the baby during pregnancy, but it also generates the force necessary to push out that tiny human during labor.

This force results from the muscle contractions that take place in the middle layer of the uterus, the myometrium.

The regulation of these muscle contractions happens at the cellular level, and it all comes down to the activity of myosin light-chain kinase by calcium ions.

This enzyme phosphorylates myosin, inducing muscle contraction.

On the other hand, this enzyme can be turned off via phosphorylation by protein kinase A, which causes the muscles to relax.

Now, during labor, uterine contractions become stronger and more frequent.

Normally, this happens at some point when the fetus is considered full term, which means all their organs are functional and it’s able to live outside mommy’s womb. This typically happens between 37 and 42 weeks’ gestation.

Sometimes labor doesn’t start even though it’s been more than 42 weeks. In these cases, it should be induced by the administration of uterine stimulants which include oxytocin, ergonovine, and prostaglandins.

In other situations the baby, the mother, or both, are at risk if the pregnancy continued.

These include fetal growth restriction, isoimmunization, premature rupture of the membranes, pre-eclampsia, or eclampsia.

Uterotonics are also indicated to augment labor when the contractions aren’t strong enough, and they have the added benefit of preventing postpartum hemorrhage by compressing uterine blood vessels. Finally they can be used for therapeutic abortion.

Okay, let’s look at the uterotonics starting with oxytocin.

This medication activates Gq protein coupled receptors, which activates the enzyme phospholipase C - or PLC for short.

PLC then cleaves a phospholipid called phosphatidylinositol 4,5-bisphosphate into inositol trisphosphate and diacylglycerol.

Inositol trisphosphate is soluble and diffuses freely through the cytoplasm and into the endoplasmic reticulum where it opens up calcium channels.

Since the calcium concentration is higher in the endoplasmic reticulum than in the cytoplasm, calcium flows out of the endoplasmic reticulum to the cytoplasm.

Calcium ions then bind to calmodulin and activate myosin light-chain kinase, inducing muscle contraction.

Now, oxytocin is given via intravenous infusion and the main indication is for labor induction. In fact, it’s the drug of choice for this purpose.

But it’s also indicated in facilitation of labor, and to prevent or treat postpartum hemorrhage. In the last case by intramuscular injection.

But oxytocin not only exerts actions on the uterus, which causes some side effects.

On blood vessels, for example, it causes vasodilation, which ultimately leads to hypotension and reflex tachycardia.

Also, oxytocin can activate antidiuretic hormone-receptors on the collecting ducts of the kidneys. Therefore, stimulating water retention.

For this reason, fluids should be carefully administered. Otherwise, they can cause water intoxication, leading to coma, or even death.

On the other hand, in patients who are suffering preeclampsia, or hypertension during pregnancy, and those with cardiac or renal disease, water retention can be an issue, and extra care must be taken.

Finally, a situation called uterine hyperstimulation can occur where uterine contractions are too long, lasting two minutes or more, or too frequent, with five or more in ten minutes.

Uterine hyperstimulation can cause uterine rupture or impaired oxygen delivery to the baby. Which are obviously serious complications. So if this happens, oxytocin administration should be discontinued right away.

Now, moving on to ergonovine, the exact mechanism of action isn’t completely understood, but it certainly stimulates uterine contraction.

Unlike oxytocin ergonovine is only used to prevent or treat postpartum hemorrhage because ergonovine can cause prolonged tetany of the myometrium, so it should not be used for induction or facilitation of labor. It can be given by intramuscular or intravenous injection.

Besides uterine contraction, ergonovine causes vasoconstriction, which increases blood pressure. So, it should be avoided in patients with hypertension.

Also, ergonovine can cause vasospasm of the arteries that perfuse the heart and trigger angina.

Other side effects include nausea, vomiting, blurred vision, and headache.

Okay, so the last type of uterotonic agents are prostaglandins, which include dinoprostone and misoprostol.

They exert their actions by stimulating Gq protein coupled receptors, just like oxytocin.

They’re also used to facilitate labor and to prevent or treat postpartum hemorrhage.

But, dinoprostone and misoprostol are also indicated to induce abortion after the administration of mifepristone or methotrexate. They can be administered orally, vaginally or intracervically.

Some side effects include nausea, vomiting, and diarrhoea, as well as uterine pain, and uterine hyperstimulation.

Finally, dinoprostone causes bronchoconstriction, so it’s contraindicated in patients with asthma.

Let’s switch gears and talk about uterine relaxants or tocolytics.

Sometimes labor begins too early. If this happens before the 37th week of gestation, the fetal organs, especially the lungs, might not be fully developed.

If the baby’s born in this condition, they may not be able to breath, or have other serious complications, like pulmonary hypertension, or intracranial hemorrhage.

So, in this case, labor can be suppressed with uterine relaxants, thus giving the fetus a few more days in the uterus.

During this time, the mother can be given glucocorticoids to stimulate maturation of the fetal lungs.

Uterine relaxants include selective β2-adrenoceptor agonists, calcium channel blockers, cyclooxygenase inhibitors and oxytocin receptor antagonists; and the indication for all of them is the same: prevention or arrest of preterm labor.

Key Takeaways

Uterine stimulants and relaxants are medications used to induce or inhibit contractions of the uterus. Uterine stimulants are also called uterotonics because they increase the tone of the muscles of the uterus. They're mainly used to induce or facilitate labor, reduce postpartum hemorrhage, and induce abortion. Examples of uterine stimulants include oxytocin, ergonovine, and prostaglandins.

Uterine relaxants, on the other hand, decrease the activity of the uterine muscles. They are also called tocolytics, where �toco-' refers to childbirth, and �-lytic' means to terminate. They're used to stop premature labor to give time for the fetal lungs to mature. Examples of uterine relaxants include elective β2-adrenoceptor agonists, calcium channel blockers, cyclooxygenase inhibitors, and oxytocin receptor antagonists.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Postpartum Hemorrhage: Prevention and Treatment" Am Fam Physician (2017)
  5. "A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour" BJOG: An International Journal of Obstetrics & Gynaecology (2015)
  6. "Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development" Journal of Visualized Experiments (2018)
  7. "Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis" Cochrane Database of Systematic Reviews (2018)
  8. "Guideline of guidelines: priapism" BJU International (2016)
  9. "Hypoxia-induced force increase (HIFI) is a novel mechanism underlying the strengthening of labor contractions, produced by hypoxic stresses" Proceedings of the National Academy of Sciences (2015)